GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » BiON PLC (LSE:BION) » Definitions » Capex-to-Revenue

BiON (LSE:BION) Capex-to-Revenue : 0.00 (As of Oct. 2022)


View and export this data going back to 2016. Start your Free Trial

What is BiON Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

BiON's Capital Expenditure for the six months ended in Oct. 2022 was £0.00 Mil. Its Revenue for the six months ended in Oct. 2022 was £0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


BiON Capex-to-Revenue Historical Data

The historical data trend for BiON's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BiON Capex-to-Revenue Chart

BiON Annual Data
Trend Sep15 Sep16 Sep17 Dec19
Capex-to-Revenue
- 0.23 0.22 0.23

BiON Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Jun19 Dec19 Jun20 Dec20 Jun21 Oct22
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.24 0.04 0.47 9.31 -

Competitive Comparison of BiON's Capex-to-Revenue

For the Shell Companies subindustry, BiON's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BiON's Capex-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BiON's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where BiON's Capex-to-Revenue falls into.



BiON Capex-to-Revenue Calculation

BiON's Capex-to-Revenue for the fiscal year that ended in Dec. 2019 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.008) / 4.463
=0.23

BiON's Capex-to-Revenue for the quarter that ended in Oct. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BiON  (LSE:BION) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


BiON Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of BiON's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BiON (LSE:BION) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Dutamas 1, D2-3-1 Solaris Dutamas 1, Kuala Lumpur, SGR, MYS, 50480
BiON PLC and its subsidiaries are engaged in research and development, provision of professional engineering consultancy, and process design services. It provides services in the areas of industrial biotechnology, pollution control, and renewable energy; and engineering, procurement, and construction of various wastewater treatment plants/systems; and development, commercialization, operation, and maintenance of renewable energy power plants. The company operates in two business segments providing consulting and contract services to customers in the renewable energy sector and the supply of power to National Grid. The consulting and contract segment generates a vast majority of its revenues.

BiON (LSE:BION) Headlines

No Headlines